138 related articles for article (PubMed ID: 33878993)
21. Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
Toussaint N; Mullins K; Snider J; Murphy B; Langham R; Gock H
Nephrology (Carlton); 2005 Apr; 10(2):142-6. PubMed ID: 15877673
[TBL] [Abstract][Full Text] [Related]
22.
Lam PW; Naimark DM; Leis JA
Perit Dial Int; 2018; 38(1):9-13. PubMed ID: 29311193
[TBL] [Abstract][Full Text] [Related]
23. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
24. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
[TBL] [Abstract][Full Text] [Related]
25. [Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review].
Tsai SM; Yan Y; Zhao HP; Wu B; Zuo L; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):747-751. PubMed ID: 30122784
[TBL] [Abstract][Full Text] [Related]
26. Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis--an update.
Diaz-Buxo JA; Crawford TL
Adv Perit Dial; 2000; 16():229-32. PubMed ID: 11045300
[TBL] [Abstract][Full Text] [Related]
27. Treatment for peritoneal dialysis-associated peritonitis.
Wiggins KJ; Craig JC; Johnson DW; Strippoli GF
Cochrane Database Syst Rev; 2008 Jan; (1):CD005284. PubMed ID: 18254075
[TBL] [Abstract][Full Text] [Related]
28. Dialysate bacterial endotoxin as a prognostic indicator of peritoneal dialysis related peritonitis.
Szeto CC; Lai KB; Chow KM; Kwan BC; Law MC; Pang WF; Ma TK; Leung CB; Li PK
Nephrology (Carlton); 2016 Dec; 21(12):1069-1072. PubMed ID: 27870228
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic availability for outpatient treatment of acute peritonitis in chronic peritoneal dialysis patients: A case series.
Makhyoun CN; Ullian ME
Am J Med Sci; 2023 Mar; 365(3):263-269. PubMed ID: 36521531
[TBL] [Abstract][Full Text] [Related]
30. Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades.
Fontán MP; Cambre HD; Rodríguez-Carmona A; Muñiz AL; Falcón TG
Perit Dial Int; 2009; 29(3):310-8. PubMed ID: 19458304
[TBL] [Abstract][Full Text] [Related]
31. Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review.
Tsai SF; Chen CH; Shu KH; Wu MJ
Intern Med; 2012; 51(13):1721-4. PubMed ID: 22790133
[TBL] [Abstract][Full Text] [Related]
32. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.
Ghali JR; Bannister KM; Brown FG; Rosman JB; Wiggins KJ; Johnson DW; McDonald SP
Perit Dial Int; 2011; 31(6):651-62. PubMed ID: 21719685
[TBL] [Abstract][Full Text] [Related]
33. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
34. Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients.
Van Matre ET; Teitelbaum I; Kiser TH
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122898
[TBL] [Abstract][Full Text] [Related]
35. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
Boudville N; Johnson DW; Zhao J; Bieber BA; Pisoni RL; Piraino B; Bernardini J; Nessim SJ; Ito Y; Woodrow G; Brown F; Collins J; Kanjanabuch T; Szeto CC; Perl J
Nephrol Dial Transplant; 2019 Dec; 34(12):2118-2126. PubMed ID: 30053214
[TBL] [Abstract][Full Text] [Related]
36. A very rare pathogen in peritoneal dialysis peritonitis:
Helvaci O; Hızel K; Guz G; Arinsoy T; Derici U
Saudi J Kidney Dis Transpl; 2019; 30(3):738-740. PubMed ID: 31249244
[TBL] [Abstract][Full Text] [Related]
37. [A contemporary situation in the antimicrobial treatment of the secondary peritonitis].
Vyhnánek F; Vranková J
Rozhl Chir; 2005 Sep; 84(9):466-71. PubMed ID: 16250620
[TBL] [Abstract][Full Text] [Related]
38. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.
Restrepo C; Chacon J; Manjarres G
Perit Dial Int; 2010; 30(6):619-25. PubMed ID: 20634438
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update.
Keane WF; Alexander SR; Bailie GR; Boeschoten E; Gokal R; Golper TA; Holmes CJ; Huang CC; Kawaguchi Y; Piraino B; Riella M; Schaefer F; Vas S
Perit Dial Int; 1996; 16(6):557-73. PubMed ID: 8981523
[TBL] [Abstract][Full Text] [Related]
40. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003.
Davenport A
Perit Dial Int; 2009; 29(3):297-302. PubMed ID: 19458302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
